IN8bio Inc. (INAB)
0.30
-0.02 (-5.21%)
At close: Jan 15, 2025, 3:59 PM
0.30
0.40%
After-hours Jan 15, 2025, 06:39 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -30.01M | -28.52M | -14.65M | -8.56M | -5.13M | -2.08M |
| Depreciation & Amortization | 2.50M | 1.10M | 788.00K | 88.00K | 96.00K | 96.00K |
| Stock-Based Compensation | 4.37M | 3.47M | 2.19M | 357.00K | 76.00K | 31.00K |
| Other Working Capital | 777.00K | -1.68M | -1.52M | 771.00K | -48.00K | -733.00K |
| Other Non-Cash Items | n/a | 4.16M | 541.00K | 368.00K | 68.00K | 70.00K |
| Deferred Income Tax | n/a | -4.16M | -541.00K | n/a | n/a | n/a |
| Change in Working Capital | -204.00K | -170.00K | -1.84M | 611.00K | 93.00K | -885.00K |
| Operating Cash Flow | -23.34M | -24.12M | -13.51M | -7.13M | -4.80M | -2.77M |
| Capital Expenditures | -600.00K | -3.71M | -309.00K | n/a | -330.00K | -757.00K |
| Acquisitions | n/a | n/a | n/a | n/a | 686.00K | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -16.00K | -309.00K | n/a | 686.00 | n/a |
| Investing Cash Flow | -600.00K | -3.71M | -309.00K | n/a | 356.00K | -757.00K |
| Debt Repayment | -798.00K | -615.00K | -709.00K | 174.00K | n/a | 1.26M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 3.28M | 61.00K | -2.66M | 23.84M | 65.00K | 14.47M |
| Financial Cash Flow | 27.04M | 8.99M | 32.95M | 24.52M | 65.00K | 8.50M |
| Net Cash Flow | 2.85M | -18.84M | 19.14M | 17.38M | -4.38M | 4.97M |
| Free Cash Flow | -23.94M | -27.83M | -13.82M | -7.13M | -5.13M | -3.53M |